Document is current

Any future updates will be listed below

Vedolizumab auch bei pädiatrischer CED wirksam

Crossref DOI link: https://doi.org/10.1007/s15014-023-4821-2

Published Online: 2023-02-15

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark